Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Bharat Biotech in-licences GSK's Shigella vaccine candidate

نشر بتاريخ

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

جارٍ التحميل...

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

Business

RBI may cut rates further after brief pause; more liquidity requirement in second half of FY26: Report

The Reserve Bank of India (RBI) is likely to cut interest rates further after a temporary pause,...

بواسطة 0 1

National

Demand for coffee seedlings surges in gulmi, supply falls short

GULMI: The demand for coffee seedlings has surged in Gulmi, creating a significant supply gap at...

بواسطة 0 18

Entertainment

Katrina Kaif and Vicky Kaushal's love story

Katrina Kaif and Vicky Kaushal's romance, now admired in Bollywood, began subtly. Their first...

بواسطة 0 24

Business

Bank loan: Retail loan stress may reverse NPA gains, CareEdge warns of unsecured segment risks in H1FY26

CareEdge Ratings anticipates a slight increase in Indian banks' NPAs by FY26's first half, driven...

بواسطة 0 26

International

Middle East crisis: 'Striking dozens of Iran missile launchers,' says Israel; two Iranian generals killed

Tensions soar as Israel targets Iranian missile sites after Tehran's retaliatory strikes. Two...

بواسطة 0 28